Saldeen T, Frisch E P
Haemostasis. 1982;11(3):161-9. doi: 10.1159/000214657.
The influence of brinase on fibrinogen levels, ethanol gelation test (EGT), fibrin content of lungs and kidneys (125I-fibrinogen) and brinase inhibitor capacity was investigated in the rat. The animals were either treated with i.v. infusions of brinase (4 mg/kg), tranexamic acid (AMCA) + brinase or heparin + AMCA + brinase. A control group was given i.v. saline, a reference group AMCA + thrombin. Brinase caused a decrease in fibrinogen levels and an increase in the incidence of positive EGT, deposition of fibrin was not observed. Infusion of brinase into rats with inhibition fibrinolytic system (AMCA), caused a more pronounced decrease in fibrinogen levels, a further increase in the incidence of positive EGT and also fibrin deposition in the kidneys. In rats treated with AMCA + thrombin a similar decrease in fibrinogen levels was recorded, the EGT was positive in all animals, and extensive fibrin deposits were observed in the kidneys and lungs of the animals. Heparinization before infusion of AMCA + brinase antagonized the lowering in fibrinogen levels and the increase in incidence of positive EGT and, moreover, fibrin deposits were no longer observed.
在大鼠中研究了纤溶酶对纤维蛋白原水平、乙醇凝胶试验(EGT)、肺和肾的纤维蛋白含量(125I-纤维蛋白原)以及纤溶酶抑制剂能力的影响。动物分别接受静脉输注纤溶酶(4mg/kg)、氨甲环酸(AMCA)+纤溶酶或肝素+AMCA+纤溶酶治疗。对照组给予静脉生理盐水,参考组给予AMCA+凝血酶。纤溶酶导致纤维蛋白原水平降低,EGT阳性发生率增加,未观察到纤维蛋白沉积。向具有纤维蛋白溶解系统抑制作用(AMCA)的大鼠输注纤溶酶,导致纤维蛋白原水平更明显降低,EGT阳性发生率进一步增加,并且在肾脏中出现纤维蛋白沉积。用AMCA+凝血酶治疗的大鼠记录到类似的纤维蛋白原水平降低,所有动物的EGT均为阳性,并且在动物的肾脏和肺中观察到广泛的纤维蛋白沉积。在输注AMCA+纤溶酶之前进行肝素化可拮抗纤维蛋白原水平的降低和EGT阳性发生率的增加,此外,不再观察到纤维蛋白沉积。